Literature DB >> 21909134

Identification of microprocessor-dependent cancer cells allows screening for growth-sustaining micro-RNAs.

D Peric1, K Chvalova, G Rousselet.   

Abstract

Micro-RNAs are deregulated in cancer cells, and some are either tumor suppressive or oncogenic. In addition, a link has been established between decreased expression of micro-RNAs and transformation, and several proteins of the RNA interference pathway have been shown to be haploinsufficient tumor suppressors. Oncogenic micro-RNAs (oncomiRs) could represent new therapeutic targets, and their identification is therefore crucial. However, structural and functional redundancy between micro-RNAs hampers approaches relying on individual micro-RNA inhibition. We reasoned that in cancer cells that depend on oncomiRs, impairing the micro-RNA pathway could lead to growth perturbation rather than increased tumorigenesis. Identifying such cells could allow functional analyses of individual micro-RNAs by complementation of the phenotypes observed upon global micro-RNA inhibition. Therefore, we developed episomal vectors coding for small hairpin RNAs targeting either Drosha or DGCR8, the two components of the microprocessor, the nuclear micro-RNA maturation complex. We identified cancer cell lines in which both vectors induced colony growth arrest. We then screened for individual micro-RNAs complementing this growth arrest, and identified miR-19a, miR-19b, miR-20a and miR-27b as major growth-sustaining micro-RNAs. However, the effect of miR-19a and miR-19b was only transient. In addition, embryonic stem cell-derived micro-RNAs with miR-20a seeds were much less efficient than miR-20a in sustaining cancer cell growth, a finding that contrasted with results obtained in stem cells. Finally, we showed that the tumor suppressor phosphatase and tensin homologue deleted on chromosome 10, a shared target of miR-19 and miR-20, was functionally involved in the growth arrest induced by microprocessor inhibition. We conclude that our approach allowed to identify microprocessor-dependent cancer cells, which could be used to screen for growth-sustaining micro-RNAs. This complementation screen unveiled functional differences between homologous micro-RNAs. Phenotypic characterization of the complemented cells will allow precise functional studies of these micro-RNAs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21909134     DOI: 10.1038/onc.2011.391

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  Silencing the double-stranded RNA binding protein DGCR8 inhibits ovarian cancer cell proliferation, migration, and invasion.

Authors:  Yuqi Guo; Peng Tian; Chuanhe Yang; Zhibing Liang; Min Li; Michelle Sims; Lu Lu; Zhan Zhang; Hongwei Li; Lawrence M Pfeffer; Junming Yue
Journal:  Pharm Res       Date:  2015-03       Impact factor: 4.200

2.  Processing of microRNA primary transcripts requires heme in mammalian cells.

Authors:  Sara H Weitz; Ming Gong; Ian Barr; Shimon Weiss; Feng Guo
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-21       Impact factor: 11.205

3.  Manipulating miRNA Expression: A Novel Approach for Colon Cancer Prevention and Chemotherapy.

Authors:  Satish Ramalingam; Dharmalingam Subramaniam; Shrikant Anant
Journal:  Curr Pharmacol Rep       Date:  2015-06-01

4.  Therapeutic manipulation of angiogenesis with miR-27b.

Authors:  Dorina Veliceasa; Dauren Biyashev; Gangjian Qin; Sol Misener; Alexander Roy Mackie; Raj Kishore; Olga V Volpert
Journal:  Vasc Cell       Date:  2015-06-24

5.  MicroRNA-27b up-regulated by human papillomavirus 16 E7 promotes proliferation and suppresses apoptosis by targeting polo-like kinase2 in cervical cancer.

Authors:  Fei Liu; Shimeng Zhang; Zhen Zhao; Xinru Mao; Jinlan Huang; Zixian Wu; Lei Zheng; Qian Wang
Journal:  Oncotarget       Date:  2016-04-12

Review 6.  Use of Personalized Biomarkers in Metastatic Colorectal Cancer and the Impact of AI.

Authors:  Simona-Ruxandra Volovat; Iolanda Augustin; Daniela Zob; Diana Boboc; Florin Amurariti; Constantin Volovat; Cipriana Stefanescu; Cati Raluca Stolniceanu; Manuela Ciocoiu; Eduard Alexandru Dumitras; Mihai Danciu; Delia Gabriela Ciobanu Apostol; Vasile Drug; Sinziana Al Shurbaji; Lucia-Georgiana Coca; Florin Leon; Adrian Iftene; Paul-Corneliu Herghelegiu
Journal:  Cancers (Basel)       Date:  2022-10-03       Impact factor: 6.575

7.  WBP2 inhibits microRNA biogenesis via interaction with the microprocessor complex.

Authors:  Hossein Tabatabaeian; Shen Kiat Lim; Tinghine Chu; Sock Hong Seah; Yoon Pin Lim
Journal:  Life Sci Alliance       Date:  2021-06-11

Review 8.  MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.

Authors:  Kenneth Kw To; Christy Ws Tong; Mingxia Wu; William Cs Cho
Journal:  World J Gastroenterol       Date:  2018-07-21       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.